ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,230,000 | -17.2% | 152,014 | +42.0% | 0.01% | 0.0% |
| Q1 2022 | $1,485,000 | -50.4% | 107,041 | +0.3% | 0.01% | -50.0% |
| Q4 2021 | $2,996,000 | -56.7% | 106,774 | -47.6% | 0.03% | -15.2% |
| Q3 2021 | $6,920,000 | +70.9% | 203,608 | +105.5% | 0.03% | -15.4% |
| Q2 2021 | $4,048,000 | +8.0% | 99,096 | +6.4% | 0.04% | +5.4% |
| Q1 2021 | $3,748,000 | -33.1% | 93,094 | -1.7% | 0.04% | -40.3% |
| Q4 2020 | $5,599,000 | +19.4% | 94,680 | -1.8% | 0.06% | -3.1% |
| Q3 2020 | $4,690,000 | +267.0% | 96,462 | +265.0% | 0.06% | +204.8% |
| Q2 2020 | $1,278,000 | +229.4% | 26,425 | +89.4% | 0.02% | +162.5% |
| Q1 2020 | $388,000 | – | 13,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |